Related Experiment Video
Updated: Apr 16, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Towards tissue-specific pharmacology: insights from the calcium-sensing receptor as a paradigm for GPCR
Katie Leach1, Arthur D Conigrave2, Patrick M Sexton1
1Monash Institute of Pharmaceutical Sciences, 381 Royal Parade, Parkville VIC, Australia.
Abstract:
The calcium-sensing receptor (CaSR) is a widely expressed G protein-coupled receptor (GPCR) that mediates numerous tissue-specific functions. Its multiple ligands and diverse roles attest to the need for exquisite control over the signaling pathways that mediate its effects. 'Biased signaling' is the phenomenon by which distinct ligands stabilize preferred receptor signaling states. The CaSR is subject to biased signaling in response to its endogenous ligands. Interestingly, the 'natural' bias of the CaSR is altered in disease states, and small molecule drugs engender biased allosteric modulation of downstream signaling pathways. Thus, biased signaling from the CaSR also has important implications pathophysiologically and therapeutically. As outlined in this review, this novel paradigm extends to other GPCRs, making the CaSR a model for studies of ligand-biased signaling and for understanding how it may be used to foster selective drug activity in different tissues.
Insights
The calcium-sensing receptor (CaSR) exhibits biased signaling, where different ligands activate specific pathways. This phenomenon is crucial in disease and drug development for targeted CaSR therapies.
Area of Science:
- Biochemistry
- Pharmacology
- Cellular Biology
Background:
- The calcium-sensing receptor (CaSR), a G protein-coupled receptor (GPCR), plays diverse tissue-specific roles.
- Precise control over CaSR signaling pathways is essential due to its multiple ligands and functions.
Purpose of the Study:
- To review the concept of biased signaling in the context of the CaSR.
- To explore the pathophysiological and therapeutic implications of CaSR biased signaling.
Main Methods:
- Review of existing literature on CaSR signaling and biased agonism.
- Analysis of how ligand-biased signaling affects CaSR function in health and disease.
Main Results:
- The CaSR exhibits biased signaling with its endogenous ligands.
- Disease states can alter the natural bias of the CaSR.
- Small molecule drugs can induce biased allosteric modulation of CaSR signaling.
Conclusions:
- Biased signaling is a critical paradigm for the CaSR, impacting disease and therapy.
- The CaSR serves as a model for studying ligand-biased signaling in GPCRs.
- Understanding CaSR biased signaling can lead to selective drug development for various tissues.
More Related Videos
Related Concept Videos
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
G-protein Coupled Receptors

